Serum ceruloplasmin-ferroxidase activity in bipolar disorder is elevated compared to major depressive disorder and schizophrenia: a controlled study

References

• Carmona F, Palacios Ò, Gálvez N, et al. Ferritin iron uptake and release in the presence of metals and metalloproteins: chemical implications in the brain. Coord Chem Rev. 2013;257(19–20):2752–2764.
   Web of Science ®Google Scholar
• Manto M. Abnormal copper homeostasis: mechanisms and roles in neurodegeneration. Toxics. 2014;2(2):327–345.
   Google Scholar
• Modabbernia A, Velthorst E, Gennings C, et al. Early-life metal exposure and schizophrenia: a proof-of-concept study using novel tooth-matrix biomarkers. Eur Psychiatry. 2016;36:1–6.
   Web of Science ®Google Scholar
• Vassiliev V, Harris ZL, Zatta P. Ceruloplasmin in neurodegenerative diseases. Brain Res Brain Res Rev. 2005;49(3):633–640.
   Google Scholar
• Gaware V, Kotade K, Dhamak K, et al. Ceruloplasmin its role and significance: a review. Int J Biol Res. 2010;1:153–162.
   Google Scholar
• Heidari M, Johnstone DM, Bassett B, et al. Brain iron accumulation affects myelin-related molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features. Mol Psychiatry. 2016;21(11):1599–1607.
   Web of Science ®Google Scholar
• Dean B, Tsatsanis A, Lam LQ, et al. Changes in cortical protein markers of iron transport with gender, major depressive disorder and suicide. World J Biol Psychiatry. 2018. doi:10.1080/15622975.
   Web of Science ®Google Scholar
• First MB, Spitzer RL, Gibbon M, et al. American Psychiatric Press, Washington DC, 1997.
   Google Scholar
• Özkürkçügil A, Aydemir Ö, Yıldız M, et al. DSM-IV Eksen I bozuklukları için yapılandırılmış klinik görüşmenin Türkçe’ye uyarlanması ve güvenilirlik çalışması. İlaç ve Tedavi Derg. 1999;12(4):233–236.
   Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62.
   PubMed Web of Science ®Google Scholar
• Akdemir A, Önsel S, Dağ İ, et al. Hamilton depresyon derecelendirme ölçeği (HDDÖ)’nin geçerliği, güvenirliği ve klinik kullanımı. Psikiyatri Psikol Psikofarmakol Derg. 1996;4:251–259.
   Google Scholar
• Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429–435.
   PubMed Web of Science ®Google Scholar
• Karadağ F, Oral ET, Aran Yalçın F, et al. Young mani derecelendirme ölçeğinin Türkiye’de geçerlik ve güvenilirliği. Türk Psikiyatri Derg. 2001;13:107–114.
   Google Scholar
• Williams JB. A structured interview guide for the Hamilton depression rating scale. Arch Gen Psychiatry. 1988;45(8):742–747.
   PubMed Web of Science ®Google Scholar
• Andreasen NC. The scale for the assesment of positive symtoms (SAPS). Iowacity (IA): University of Iowa Press; 1984.
   Google Scholar
• Erkoç Ş, Arkonaç O, Ataklı C, et al. Pozitif semptomları değerlendirme ölçeğinin güvenirliği ve geçerliliği. Düşünen Adam. 1991;4:20–24.
   Google Scholar
• Andreasen NC. The scale for the assesment of negative symptoms (SANS). Iowacity (IA): University of Iowa Press; 1983.
   Google Scholar
• Erkoç Ş, Arkonaç O, Ataklı C, et al. Negatif semptomları değerlendirme ölçeğinin güvenirliği ve geçerliliği. Düşünen Adam. 1991;4:16–19.
   Google Scholar
• Erel O. Automated measurement of serum ferroxidase activity. Clin Chem. 1998;44(11):2313–2319.
   PubMed Web of Science ®Google Scholar
• Twomey PJ, Viljoen A, Reynolds TM, et al. Non-ceruloplasmin-bound copper in routine clinical practice in different laboratories. J Trace Elem Med Biol. 2008;22(1):50–53.
   Web of Science ®Google Scholar
• Sharma S, Sood S, Sharma A, et al. Estimation of serum zinc and copper levels patients with schizophrenia: a preliminary study. SL J Psychiatry. 2014;5(1):14–17.
   Google Scholar
• Nechifor M, Vaideanu C, Palamaru I, et al. The influence of some antipsychotics on erythrocyte magnesium and plasma magnesium, calcium, copper and zinc in patients with paranoid schizophrenia. J Am Coll Nutr. 2004;23(5):549S–551S.
   PubMed Web of Science ®Google Scholar
• Wolf TL, Kotun J, Meador Woodruff JH. Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia. Schizophr Res. 2006;86(1–3):167–171.
   Web of Science ®Google Scholar
• Yanik M, Kocyigit A, Tutkun H, et al. Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia. Biol Trace Elem Res. 2004;98(2):109–117.
   Web of Science ®Google Scholar
• Demily C, Parant F, Cheillan D, et al. Screening of Wilson’s disease in a psychiatric population: difficulties and pitfalls. A preliminary study. Ann Gen Psychiatry. 2017;16:19.
   Web of Science ®Google Scholar
• Vidović B, Dorđević B, Milovanović S, et al. Selenium, zinc, and copper plasma levels in patients with schizophrenia: relationship with metabolic risk factors. Biol Trace Elem Res. 2013;156(1–3):22–28.
   PubMed Web of Science ®Google Scholar
• Rahman A, Azad MA, Hossain I, et al. Zinc, manganese, calcium, copper, and cadmium level in scalp hair samples of schizophrenic patients. Biol Trace Elem Res. 2009;127(2):102–108.
   PubMed Web of Science ®Google Scholar
• Ghanem AEA, Ali EM, El-Bakary AA, et al. Copper and Zinc levels in hair of both schizophrenic and depressed patients. Journal of Forensic Medicine and Clinical Toxicology. 2009;17:89–102.
   Google Scholar
• Zimbrean PC, Schilsky ML. Psychiatric aspects of Wilson disease: a review. Gen Hosp Psychiatry. 2014;36(1):53–62.
   PubMed Web of Science ®Google Scholar
• Liu T, Lu QB, Yan L, et al. Comparative study on serum levels of 10 trace elements in schizophrenia. PLoS One. 2015;10(7):e0133622.
   Web of Science ®Google Scholar
• Virit O, Selek S, Bulut M, et al. High ceruloplasmin levels are associated with obsessive compulsive disorder: a case control study. Behav Brain Funct. 2008;4(1):52.
   Web of Science ®Google Scholar
• González-Estecha M, Trasobares EM, Tajima K, et al. Trace elements in bipolar disorder. J Trace Elem Med Biol. 2011;25(Suppl 1):S78–S83.
   PubMed Web of Science ®Google Scholar
• Carta M, Mura G, Sorbello O, et al. Quality of life and psychiatric symptoms in Wilson’s disease: the relevance of bipolar disorders. Clin Pract Epidemiol Ment Health. 2012;8:102–109.
   PubMedGoogle Scholar
• Stelzhammer V, Haenisch F, Chan MK, et al. Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients. Int J Neuropsychopharmacol. 2014;17(10):1599–1608.
   PubMed Web of Science ®Google Scholar
• Chen X, Li Y, Zhang T, et al. Association of serum trace elements with schizophrenia and effects of antipsychotic treatment. Biol Trace Elem Res. 2018;181(1):22–30.
   Web of Science ®Google Scholar
• Schoonover KE, Queern SL, Lapi SE, et al. Impaired copper transport in schizophrenia results in a copper-deficient brain state: a new side to the dysbindin story. World J Biol Psychiatry. 2018. doi:10.1080/15622975.2018.1523562.
   Web of Science ®Google Scholar
• Devanarayanan S, Nandeesha H, Kattimani S, et al. Elevated copper, hs C-reactive protein and dyslipidemia in drug free schizophrenia: Relation with psychopathology score. Asian J Psychiatr. 2016;24:99–102.
   PubMed Web of Science ®Google Scholar
• Li Z, Liu Y, Li X, et al. Association of elements with schizophrenia and intervention of selenium supplements. Biol Trace Elem Res. 2018;183(1):16–21.
   Web of Science ®Google Scholar
• Cao B, Yan L, Ma J, et al. Comparison of serum essential trace metals between patients with schizophrenia and healthy controls. J Trace Elem Med Biol. 2019;51:79–85.
   PubMed Web of Science ®Google Scholar
• Firth J, Carney R, Stubbs B, et al. Nutritional deficiencies and clinical correlates in first-episode psychosis: a systematic review and meta-analysis. Schizophr Bull. 2018;44(6):1275–1292.
   PubMed Web of Science ®Google Scholar
• Siwek M, Styczeń K, Sowa-Kućma M, et al. The serum concentration of copper in bipolar disorder. Psychiatr Pol. 2017;51(3):469–481.
   Web of Science ®Google Scholar
• Pradeep AS, Naga Raju GJ, Sattar SA, et al. Trace elemental distribution in the scalp hair of bipolars using PIXE technique. Med Hypotheses. 2014;82(4):470–477.
   PubMed Web of Science ®Google Scholar
• Li Z, Wang W, Xin X, et al. Association of total zinc, iron, copper and selenium intakes with depression in the US adults. J Affect Disord. 2018;228:68–74.
   PubMed Web of Science ®Google Scholar
• Styczeń K, Sowa-Kućma M, Dudek D, et al. Zinc and copper concentration do not differentiate the bipolar disorder from major depressive disorder. Psychiatr Pol. 2018;52(3):449–457.
   Web of Science ®Google Scholar
• Styczeń K, Sowa-Kućma M, Siwek M, et al. Study of the serum copper levels in patients with major depressive disorder. Biol Trace Elem Res. 2016;174(2):287–293.
   PubMed Web of Science ®Google Scholar
• Ni M, You Y, Chen J, et al. Copper in depressive disorder: a systematic review and meta-analysis of observational studies. Psychiatry Res. 2018;267:506–515.
   Web of Science ®Google Scholar
• Virit O, Altindag A, Selek S, et al. Increased plasma ceruloplasmin levels in schizophrenia. Klinik Psikofarmakoloji Bulteni. 2008;18(4):282–287.
   Google Scholar
• Kaya MC, Bez Y, Selek S, et al. No effect of antidepressant treatment on elevated serum ceruloplasmin level in patients with first-episode depression: a longitidunal study. Arch Med Res. 2012;43(4):294–297.
   Web of Science ®Google Scholar
• Lee MY, Kim EY, Kim SH, et al. Discovery of serum protein biomarkers in drug-free patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2016;69:60–68.
   PubMed Web of Science ®Google Scholar
• Bajpai A, Verma AK, Srivastava M, et al. Oxidative stress and major depression. J Clin Diagn Res. 2014;8(12):4–7.
   Google Scholar
• Maes M, Carvalho AF. The compensatory immune-regulatory reflex system (CIRS) in depression and bipolar disorder. Mol Neurobiol. 2018;55(12):8885–8903.
   PubMed Web of Science ®Google Scholar
• Arnal N, Cristalli DO, de Alaniz MJ, et al. Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives. Brain Res. 2010;1319:118–130.
   PubMed Web of Science ®Google Scholar
• Valkanova V, Ebmeier KP, Allan CL. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord. 2013;150(3):736–744.
   PubMed Web of Science ®Google Scholar
• Baumann PS, Griffa A, Fournier M, et al. Impaired fornix-hippocampus integrity is linked to peripheral glutathione peroxidase in early psychosis. Transl Psychiatry. 2016;6(7):e859. doi:10.1038/tp.2016.117.
   Web of Science ®Google Scholar
• Tunc S, Atagun MI, Neselioglu S, et al. Ischemia-modified albumin: a unique marker of global metabolic risk in schizophrenia and mood disorders. Psychiatry and Clinical Psychopharmacology. 2018. doi:10.1080/24750573.2018.1517466.
   Web of Science ®Google Scholar
• Boozalis T, Devaraj S, Okusaga OO. Correlations between body mass index, plasma high-sensitivity C-reactive protein and lipids in patients with schizophrenia. Psychiatr Q. 2018 Oct 12. doi:10.1007/s11126-018-9606-3.
   Web of Science ®Google Scholar
• Bond DJ, Andreazza AC, Hughes J, et al. Association of peripheral inflammation with body mass index and depressive relapse in bipolar disorder. Psychoneuroendocrinology. 2016;65:76–83.
   PubMed Web of Science ®Google Scholar
• Kul M, Kara M, Unal F, et al. Serum copper and ceruloplasmin levels in children and adolescents with attention deficit hyperactivity disorder. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 2014;24(2):139–145.
   Web of Science ®Google Scholar